AnalystsSteve BrozakSteve Brozak's Stock Forecasts
AnalystsSteve Brozak
Sectors:
Analyst Ranking
Bottom 8%
#4607 out of 4986 analysts
Average Return
-36.21%
Win Rate
9%1 out of 11
Risk vs Reward
Poor
Good
Steve Brozak's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Cidara Therapeutics IncCDTX | +36.80% | $44.95 | $61.49 | 2025-06-22 - 2025-08-19 | Strong Buy |
Steve Brozak Analyst Color
Get additional color on Steve Brozak's coverage of popular stocks
Steve Brozak's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Celularity IncCELU | 1 | Buy | $6.00 | +66.20% | Initiates Coverage On | 2 days ago |
Cidara Therapeutics IncCDTX | 2 | Strong Buy | $45.00 | -26.82% | Reiterates | 2 months ago |
Marker Therapeutics IncMRKR | 1 | Strong Buy | $12.50 | +1,006.19% | Reiterates | 5 months ago |
Contrafect CorpCFRXQ | 2 | Strong Buy | $560.00 | N/A | Upgrades | 3 years ago |
Paratek Pharmaceuticals IncPRTK | 1 | Strong Buy | $11.00 | N/A | Upgrades | 4 years ago |
Omeros CorpOMER | 1 | Strong Buy | $100.00 | N/A | Maintains | 4 years ago |
Redhill Biopharma LtdRDHL | 2 | Buy | $16,000.00 | N/A | Downgrades | 4 years ago |
Cohbar IncCWBR | 1 | Buy | $135.00 | N/A | Initiates Coverage On | 5 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.